Clock Foundation
Advancing the science of epigenetic aging clocks to predict healthspan and lifespan, while making testing more accessible and affordable.
Advancing the science of epigenetic aging clocks to predict healthspan and lifespan, while making testing more accessible and affordable.
Clock Foundation Analysis
Clock Foundation is a biotech startup founded in 2020, based in Los Angeles, California. The company is focused on advancing the science of epigenetic aging clocks to predict healthspan and lifespan, while also striving to make testing more accessible and affordable.
Their mission involves making epigenetic aging clocks more accessible for preclinical and clinical research, including innovative measurements such as PhenoAge and GrimAge. Clock Foundation also works on developing epigenetic clocks for various mammalian species and aims to reduce the cost of epigenetic testing.
Furthermore, the company is focused on conducting mechanistic studies and developing more effective biomarkers for predicting healthspan and lifespan. These efforts include establishing a rapid, safe, and effective testing protocol for humans, model organisms, and companion pets, while also investigating various aging indicators like epigenetic aging clocks, immunosenescence markers, and organ failure.
In the long-term, Clock Foundation aims to validate different aging biomarkers as surrogate trial outcomes, positioning itself as a key player in the biopharma and biotechnology industries.
There is no investment information
No recent news or press coverage available for Clock Foundation.
We care about your data, and we'd love to use cookies make your experience better.
